FibroGen Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 05:50PM GMT
Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

And good afternoon, everybody, and thank you for joining us for the second day of the 41st Annual Cowen Healthcare Conference. I'm Yaron Werber, biotech analyst here at Cowen with my colleague, Brendan Smith. And it's a great pleasure for us to moderate the fireside chat with FibroGen.

Today, we have Enrique Conterno, who's the CEO; and Mike Tung, VP of Investor Relations and Strategy. Gentlemen, thanks so much for joining us. We appreciate it.

Enrique A. Conterno - FibroGen, Inc. - CEO & Director

Thank you very much for the invitation, Yaron.

Questions and Answers:

Yaron Benjamin Werber - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Absolutely. So Enrique, maybe the timing for this is good in a way, just given some of the news from yesterday, obviously, wasn't prepped that way by chance. But maybe give us a little bit of a sense related to the news flow
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot